Medical Devices — Restructuring (Note 12)
Business Segments · Restructuring (Note 12)Johnson & Johnson Medical Devices — Restructuring (Note 12) increased by 100.0% to $200.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 614.3%, from $28.00M to $200.00M. Over 2 years (FY 2021 to FY 2024), Medical Devices — Restructuring (Note 12) shows a downward trend with a -18.4% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ3 2025
Rolls up toRestructuring Charges
How to read this metric
High restructuring costs indicate active efforts to improve efficiency, which may lead to future margin improvements.
Detailed definition
This metric tracks the costs associated with reorganizing the medical technology segment's operations, such as workforce...
Peer comparison
Commonly reported by large-cap companies undergoing periodic operational transformation.
Metric ID:
jnj_segment_medtech_restructuring_note_12Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00M | $100.00M | $100.00M | $0.00 | $100.00M | $100.00M | $100.00M | $235.00M | $27.00M | $100.00M | $28.00M | $45.00M | $100.00M | $100.00M | $200.00M |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | +0.0% | +0.0% | +135.0% | -88.5% | +270.4% | -72.0% | +60.7% | +122.2% | +0.0% | +100.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +135.0% | — | — | -88.1% | — | +270.4% | +0.0% | +614.3% |
Range$0.00 – $235.00M
CAGR+21.9%
Avg YoY Growth+116.4%
Median YoY Growth+0.0%
Current Streak4 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medical devices — restructuring (note 12)?
- Johnson & Johnson (JNJ) reported medical devices — restructuring (note 12) of $200.00M in Q3 2025.
- How has Johnson & Johnson's medical devices — restructuring (note 12) changed year-over-year?
- Johnson & Johnson's medical devices — restructuring (note 12) increased by 614.3% year-over-year, from $28.00M to $200.00M.
- What is the long-term trend for Johnson & Johnson's medical devices — restructuring (note 12)?
- Over 2 years (2021 to 2024), Johnson & Johnson's medical devices — restructuring (note 12) has grown at a -18.4% compound annual growth rate (CAGR), from $300.00M to $200.00M.
- What does medical devices — restructuring (note 12) mean?
- Costs incurred to reorganize or streamline the medical technology business operations.